comments feedApril 24 2018 | Contributed by Herbert Smith Freehills LLP From ILO Background to latest announcements What are the PRA and FCA saying now? PRA confirms approach to incoming branches and subsidiarisation Impact on services business Recent announcements made by the PRA and FCA clarify their approach to Brexit following the European Council’s agreement to […]
PRA and FCA clarify impact of Brexit transition for insurance sector
June 19, 2018 by Leave a Comment
WuXi PharmaTech Cayman : and PRA Health Sciences Restructure Relationship in China
January 7, 2016 by Leave a Comment
SHANGHAI, China and RALEIGH, N.C., 2015-12-08 01:00 CET (GLOBE NEWSWIRE) — WuXi PharmaTech (Cayman) Inc. (NYSE:WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, and PRA Health Sciences, Inc. (NASDAQ:PRAH), a leading global clinical contract research organization, today announced a restructuring of their relationship for the […]
